SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

AGHAZADEH TABRIZI, Mojgan
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.610
EU - Europa 4.193
AS - Asia 1.968
SA - Sud America 34
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 5
Totale 15.826
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.565
DE - Germania 1.833
CN - Cina 979
UA - Ucraina 622
TR - Turchia 466
SG - Singapore 422
RU - Federazione Russa 404
IT - Italia 372
GB - Regno Unito 324
SE - Svezia 230
FI - Finlandia 204
PL - Polonia 60
BE - Belgio 42
CA - Canada 42
FR - Francia 32
VN - Vietnam 30
BR - Brasile 24
CZ - Repubblica Ceca 17
HK - Hong Kong 13
LT - Lituania 13
ID - Indonesia 11
NL - Olanda 10
IN - India 9
PK - Pakistan 9
AU - Australia 8
EU - Europa 7
IL - Israele 6
AR - Argentina 5
RO - Romania 5
AT - Austria 4
CL - Cile 4
IR - Iran 4
KR - Corea 4
GR - Grecia 3
IE - Irlanda 3
MA - Marocco 3
BG - Bulgaria 2
CH - Svizzera 2
JP - Giappone 2
MX - Messico 2
NP - Nepal 2
TH - Thailandia 2
TW - Taiwan 2
BD - Bangladesh 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
HU - Ungheria 1
IQ - Iraq 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
MC - Monaco 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 15.826
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.266
Fairfield 1.203
Houston 728
Jacksonville 696
Ann Arbor 684
Ashburn 606
Chandler 574
Wilmington 496
Seattle 495
Santa Clara 456
Cambridge 393
Singapore 344
Izmir 220
Beijing 197
Nanjing 185
Ferrara 152
Princeton 145
Boardman 142
San Diego 110
Shanghai 91
Milan 81
Bremen 74
Helsinki 68
Shenyang 61
Los Angeles 60
Nanchang 59
Warsaw 59
New York 48
Changsha 46
Hebei 44
San Mateo 43
Munich 39
Brussels 38
Jiaxing 38
London 38
Tianjin 36
Dong Ket 29
Falls Church 29
Dearborn 28
Jinan 27
Philadelphia 25
Redwood City 25
Mountain View 22
Addison 21
Zhengzhou 21
Kunming 20
Toronto 17
Brno 15
Guangzhou 15
Orange 15
Auburn Hills 14
Indiana 14
Falkenstein 13
Frankfurt am Main 13
Washington 13
Ningbo 12
Norwalk 12
Des Moines 11
Hangzhou 11
Tappahannock 11
Bari 10
Espoo 10
Hong Kong 10
Jakarta 10
Taizhou 8
Mcallen 7
Montréal 7
Chicago 6
Kilburn 6
Ottawa 6
Redmond 6
Taunsa 6
Amsterdam 5
Düsseldorf 5
Haikou 5
Lanzhou 5
Acton 4
Chiswick 4
Chongqing 4
Hefei 4
San Francisco 4
Verona 4
Vilnius 4
Yellow Springs 4
Florence 3
Guelph 3
Hounslow 3
Mysore 3
Padova 3
Prescot 3
Tel Aviv 3
Vilvoorde 3
Xian 3
Albany 2
Bangkok 2
Buenos Aires 2
Calvizzano 2
Chengdu 2
Dublin 2
Federal 2
Totale 10.633
Salva come PNG Salva come JPEG
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 342
Handbook of Cannabis and Related Pathologies 260
A glance at adenosine receptors: Novel target for antitumor therapy 202
The A3 adenosine receptor: history and perspectives 167
A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines 165
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor 161
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 161
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 158
A3 adenosine receptor antagonists: History and future perspectives 158
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 157
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 155
A [3+2] nitrile oxide intermolecular cycloaddition approach to 4,5-dihydro-3(2H)-furanone and 3(2H)-furanone ring systems: application to the formal synthesis of (±)-ascofuranone and geiparvarin. 154
Design, Synthesis, DNA Binding, and Biological Evaluation of Water-Soluble Hybrid Molecules Containing Two Pyrazole Analogues of the Alkylating Cyclopropylpyrroloindole (CPI) Subunit of the Antitumor Agent CC-1065 and Polypyrrole Minor Groove Binders. 152
Design, synthesis and in vitro cytotoxicity of a cis-dichloroplatinum(II) complex linked to the minor groove binder stallimycin 150
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 149
Geiparvarin analogs. 2. Synthesis and cytostatic activity of 5-(4-arylbutadienyl)-3(2H)-furanones and of N-substituted 3-(4-oxo-2-furanyl)-2-buten-2-yl carbamates. 148
DNA minor groove binders as potential antitumor and antimicrobial agents 148
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles 147
Synthesis and biological evaluation of 2-and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization 146
Adenosine receptors and human melanoma 146
Geiparvarin Analogs. 3. Synthesis and cytostatic activity of 3(2H)-furanone and 4,5-dihydro-3(2H)-furanone congeners of geiparvarin, containing a geraniol-like fragment in the side chain 145
Blockade of A2A receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata 145
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3’,4’,5’-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 145
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 143
Design, synthesis and growth inhibition activity of bis-epoxyethyl derivatives of stallimycin modified on the amidino moiety 142
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 141
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 141
Hybrid molecules based on distamycin A as potential antitumor agents 141
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 141
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 139
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 137
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 137
Allosteric modulators for the A1-adenosine receptor 137
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 137
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 136
Synthesis and biological evaluation of 2-(3 ',4 ',5 '-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors 135
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 135
Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3 ',4 ',5 '-trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents 135
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 134
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 133
Novel 8-heterocyclyl xanthine derivatives in drug development - An update 133
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 132
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 130
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 130
Recent improvements in the development of A2B adenosine receptor agonists. 129
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxyphenylsulfonyl)-5-aryl thiophenes as a new class of antitubulin agents 128
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 127
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 125
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D 1 or D2 dopamine receptor agonists 124
Allosteric enhancers for A(1) adenosine receptor 123
Hybrid molecules between distamycin A and active moieties of antitumor agents 122
null 121
null 121
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 120
Involvement of globus pallidus in the antiparkinsonian effects of adenosine A2A receptor antagonists. 120
Synthesis and Biological Evaluation of 1-Methyl-2-(3’,4’,5’-Trimethoxybenzoyl)-3-Amino Indoles as a New Class of Antimitotic Agents and Tubulin Inhibitors 120
null 120
Concise Synthesis and Biological Evaluation of 2-Aroyl-5-Amino Benzo[b]thiophene Derivatives As a Novel Class of Potent Antimitotic Agents 119
Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2receptor agonists 119
Structure-activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A(3) adenosine receptor antagonists. 118
null 118
Microwave-assisted synthesis of substituted 2,4-diarylthiazoles and their evaluation as anticancer agents 117
Recent improvements in the development of A2B adenosine receptor agonists 117
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 116
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 116
Structure-activity relationships around the KN-62, a potent antagonist of the P2X(7)receptor 115
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and linked heterocycles as template for the adenosine receptor antagonism: medicinal chemistry approach and SAR considerations. 114
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 114
null 113
New synthesis of diazepino[3,2,1-ij]quinoline and pyrido[1,2,3-de] quinoxalines via addition-elimination followed by cycloacylation 113
null 112
null 112
Recent developments in A2B adenosine receptor ligands 112
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease. 112
Recent developments in the field of adenosine receptor ligands. 111
null 110
New 2-arylpyrazolo[4,3-c]quinoline derivates as potent and selective human A3 adenosine receptor antagonists 110
null 109
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 108
Synthesis and biological evaluation of novel N-6-[4-(substituted) sulfonamidophenylcarbamoyl]adenosine-5 '-uronamides as A(3) adenosine receptor agonists 107
null 107
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1- yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A 1 adenosine receptor 106
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 105
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 105
null 104
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 104
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A(3) adenosine receptors in human tumor cell lines 103
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor 103
null 103
Preparation of substituted purinylpyrazolylacetamides as adenosine A2B receptor antagonists. 101
New strategies for the synthesis of A(3) adenosine receptor antagonists 101
Recent developments in the field of A(2A) and A(3) adenosine receptor antagonists 100
Hybrid molecules containing benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha-bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukaemia cells 99
Synthesis and biological evaluation of 2-substituted-4-(3 ',4 ',5 '-trimethoxyphenyl)-5-aryl thiazoles as anticancer agents 99
Design, synthesis, and biological evaluation of C-9- and C-2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A(2A) and A(3) adenosine receptors antagonists 97
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A(3) adenosine receptor antagonists 97
null 96
A structural study of new potent and selective antagonists to the A(2B) adenosine receptor 94
Recent developments in the field of adenosine receptor ligands 92
null 92
Totale 12.950
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.606
Totale 63.366
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.590 0 0 0 0 0 329 239 282 228 286 173 53
2020/20212.081 267 203 85 229 141 221 55 228 43 267 210 132
2021/20221.546 58 144 147 53 98 78 79 53 57 118 150 511
2022/20231.389 142 82 26 183 291 209 58 109 171 10 67 41
2023/2024752 67 94 43 28 56 111 38 74 13 10 11 207
2024/20251.244 65 101 246 128 370 334 0 0 0 0 0 0
Totale 16.001